from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2788/sirR

LFCtreatmentdescriptionclass of inhibitor

-1.020

Amikacinug/mL Amikacintranslation

-0.647

Cap5-10ug/mL Capreomycintranslation

-0.669

Rox10-50 ug/mL Roxithromycintranslation

-0.487

SM2-5 ug/mL Streptomycintranslation

-1.586

Tet5-10 ug/mL Tetracyclinetranslation

-0.826

Rif0.2-5ug/mL Rifampicintranscription

-1.251

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.972

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.254

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.813

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.351

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.883

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.216

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

-2.904

NaN30.2-2 mM Sodium aziderespiration

-0.119

Nigericin50 uM Nigericinrespiration

2.176

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.369

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.197

menadione6-10 ug/mL Menadionerespiration

0.008

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.078

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.177

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.159

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

0.175

Amp0.2mg/mL AmpicillincellWall

0.319

Cephalexin20-100 ug/mL CephalexincellWall

-0.452

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.813

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.897

EMB10-20 ug/mL EthambutolcellWall

-0.005

Eta12-40 ug/mL EthionamidecellWall

0.259

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.351

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.570

BZA0.12 mg/mL BenzamidearomaticAmides

0.017

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.367

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.185

H2O24 mM hydrogen peroxideDNAdamaging

0.376

Levo10 ug/mL LevofloxacinDNAdamaging

0.015

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.051

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.220

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.346

Antimycin12.5-50 ug/mL Antimycin A?

-0.062

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.191

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.108

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.746

PA8240.2-2 ug/mL PA-824?

1.215

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.602

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.530

Verapamil50 uM Verapamil?

-2.574

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?